MedTrace Logo

A Multilevel Intervention to Improve Uptake of Gastrointestinal Cancer Screening: a Cluster Randomized Clinical Trial

NCT06830304 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15000

Last updated 2025-02-17

No results posted yet for this study

Summary

This study is a cluster randomized controlled trial aimed at evaluating the effectiveness of a multi-level intervention strategy in improving adherence to gastrointestinal cancer screening. Communities will be randomly assigned as the unit of randomization to either intervention or control group. The study population includes community residents aged 50-74 years. Communities in the intervention group will receive multi-level interventions including health education, patient navigation services, and appointment assistance, while communities in the control group will maintain routine screening management. All participants will be followed up for 90 days to track their endoscopy appointment and completion rates. The main research question is:

Can community-based multi-level intervention effectively improve adherence to gastrointestinal cancer screening among community residents?

Conditions

  • Screening Compliance

Interventions

BEHAVIORAL

Multi-level Education and Navigation Program for Gastrointestinal Cancer Screening

This multi-level intervention consists of two major components implemented at community, healthcare provider, and individual levels: Education Component: 1. Community level: Public awareness campaigns and educational sessions 2. Provider level: Training on screening guidelines and communication skills 3. Individual level: Tailored educational materials and one-on-one counseling Navigation Component: 1. Patient needs assessment and barrier identification 2. Personalized navigation services including: Appointment scheduling assistance Transportation coordination Insurance/financial counseling Reminder calls/messages Social/psychological support

BEHAVIORAL

Health education

Education Component: 1. Community level: Public awareness campaigns and educational sessions 2. Provider level: Training on screening guidelines and communication skills

Sponsors & Collaborators

  • Chongqing University Cancer Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-16
Primary Completion
2025-03-30
Completion
2025-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06830304 on ClinicalTrials.gov